在癌症中对miR-214相关标进行彻底和最新的研究
Bayu Indra Sukmana1, Sulieman Ibraheem Shelash Al-Hawary2, Munther Abosaooda3
1Departement of Oral Biology, Lambung Mangkurat University, Banjarmasin, Indonesia.
Pathology, research and practice
|September 3, 2023
概括
微RNAs (miRNAs) 是癌症的关键调节者. 这篇评论强调微RNA-214 (miR-214) 是瘤发育和扩散的重要因素,主要是通过诱导癌细胞的亡.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 癌症涉及影响基因表达的遗传异常.
- 微RNA (miRNA) 是一种非编码的RNA,可以在转录后调节基因表达.
- miRNAs通过控制关键的生物过程来影响瘤的发展.
研究的目的:
- 审查微RNA-214 (miR-214) 在瘤条件下的多方面的作用.
- 为了突出miR-214作为癌症调节器的功能.
- 讨论miR-214与瘤出现和进展之间的联系.
主要方法:
- 关于miR-214和癌症的最新研究的文献综述.
- 分析miR-214的基因组位置和与DNM3基因的关系.
- 在癌症生物学中检查miR-214的调节功能.
主要成果:
- miR-214与瘤发育和转移有关.
- 位于DNM3基因附近的miR-214在诱导癌细胞的亡中起作用.
- 最近的研究将miR-214与瘤发生的各个方面联系起来.
结论:
- 作为癌症调节剂,miR-214表现出复杂和多方面的功能.
- 了解miR-214的作用对于癌症研究和治疗至关重要.
- miR-214的主要功能是促进癌细胞的亡.
相关概念视频
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Mitogens and the Cell Cycle
6.6K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K
lncRNA - Long Non-coding RNAs
8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
Metastasis
5.6K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.6K


